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Abstract
Objective—To assess whether monitoring sedation status using bispectral index (BIS) as an adjunct
to clinical evaluation was associated with a reduction in the total amount of sedative drug used in a
12 h period.
Design—Prospective randomized controlled clinical trial.
Setting—Tertiary care neurocritical care unit.
Patients—Sixty-seven mechanically ventilated adult patients receiving continuous intravenous
sedation with propofol.
Interventions—Sedation monitoring using clinical assessment with the Ramsay scale (Ramsay-
alone group) or clinical assessment plus BIS monitoring (BIS-augmentation group). Subjects were
randomized to Ramsay-alone (n = 35), or BIS-augmentation (n = 32). Nurses adjusted the dose of
propofol to a Ramsay of 4, or a Ramsay of 4 and BIS between 60 and 70.
Measurements and Main Results—Patients in the BIS-augmentation group received
significantly less propofol by volume (93.5 ml vs. 157.8 ml, respectively; P < .015), and had lower
infusion rates (14.6 vs. 27.9 mcg/kg/min; P = .003). There is a lower risk of propofol infusion
exceeding manufacturer’s recommended dosing guides in the BIS-augmentation group versus the
Ramsay-alone group (0 vs. 23%, P = .0052). The BIS-augmentation group woke up much quicker
than those in the Ramsay-alone group (1.2 vs. 7.5 min; P < .0001).
Conclusions—BIS-augmented sedation monitoring resulted in a marked reduction in the total dose
of sedative used to achieve the same level of clinical sedation resulting in shortened time to wake up
without any measurable adverse effects. Physiologic sedation assessment tools may provide a useful
means of improving the care of sedated critically ill patients.
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Critically ill patients often require continuous intravenous (IV) sedation to facilitate medical
and nursing interventions such as mechanical ventilation, prevent recall of unpleasant events,
and maintain a safe environment [1]. Oversedation can result in delayed weaning from
mechanical ventilation and increased length of stay [2–4] while undersedation may result in
patient recall of unpleasant events, increased oxygen consumption, ventilatory dysynchrony,
and vital sign instability [5–11].
Currently, care givers most commonly use observational assessment, with tools such as
sedation assessment scales, to monitor and inform sedation treatment decisions. These tools,
however, were not designed for continuous assessment and lack adequate precision and
interrater reliability [1,12–17]. The Ramsay scale, a frequently used observational tool, is one
such example. The Ramsay scale is a single-item, six-level scale in which the assessor provides
a score between 1 and 6 that describe state and responsiveness to stimuli [18]. The original
manuscript describes the scale:
Awake levels were: 1, patient anxious and agitated or restless or both; 2, patient co-
operative, orientated, and tranquil; 3, patient responds to commands only. Asleep
levels were dependent on the patient’s response to a light glabellar tap or loud auditory
stimulus: level 4, a brisk response; 5, a sluggish response; and 6, no response [18].
Neurophysiological monitors such as the bispectral index (BIS) monitor (Aspect) and Sedline
(Hospira) monitor have been proposed as a means of near-continuous assessment of patient
level of sedation. The BIS value is a numerical value ranging from 0 to 100 and represents a
signal processed electroencephalographic (EEG) value derived from proprietary software
[19]. BIS-augmented sedation assessment has been extensively studied as a component of intra-
operative care and found to be associated with a decrease in sedative use [20–22]; however,
evidence supporting its value in ICU sedation monitoring is limited. BIS-augmented sedation
assessment has therefore not been widely adopted into contemporary ICU practice [23,24].
This study seeks to explore whether BIS monitoring provides additional value to traditional
observational assessment in selecting an ideal level of patient sedation for ventilated patients
in the ICU setting. The specific purpose of this study was to assess whether BIS monitoring
can reduce sedative dose requirements while preventing undersedation events.
Methods
This randomized clinical trial divided subjects into two groups. Both groups received the
standard of care for sedation assessment. One group received the standard of care plus BIS
monitoring. The study was conducted over the course of a single clinical nursing shift (12 h).
Subjects and Setting
Subjects were considered eligible for study inclusion if they were adult, mechanically
ventilated patients admitted to the neurocritical care unit (NCCU) of a tertiary care hospital
with a primary neurological or neurosurgical diagnosis and currently receiving continuous
intravenous (IV) sedation with propofol. Nurses and physicians in the NCCU had been using
the Ramsay scale and BIS monitoring prior to the onset of this study and were familiar with
both tools. Subjects were excluded if they had bifrontal brain injury as this may impair the
reliability of electro-encephalographic-based monitoring (BIS and EEG), required deep
(barbiturate coma) sedation, or were admitted for status epilepticus. The Institutional Review
Board reviewed and approved the protocol.
Olson et al. Page 2














Demographic data were abstracted directly from the electronic healthcare record. For both
groups, observational assessments of sedation were scored using the Ramsay scale and
documented as a routine component of nursing care. Within the BIS-augmented group,
physiologic assessments of sedation were additionally scored using the BIS monitor and
documented as routine component of nursing care; sedative use was measured as the rate of
propofol (measured in milliliters) infused each hour as well as the total volume of drug infused
in the 12 h study period; these data were obtained from chart abstraction. Recovery time was
scored as the time in minutes and seconds beginning with the cessation of propofol infusion
and ending with the time at which an independent assessor (advance practice nurse not affiliated
with this study) deemed the patient to be awake enough to provide a reliable neurologic exam;
the recovery time was obtained at 4 p.m. on the day of study. Undersedation events were scored
as any self-initiated medical support device removal (intravenous or intra-arterial catheters,
endotracheal tubes or cerebral pressure monitoring devices), or any period of ventilatory
asynchrony; undersedation events were documented by the care nurse on an undersedation
event form designed for this study. Injury severity and illness severity were hypothesized
covariates of sedative use. Injury severity was scored using the Glasgow Coma Scale (GCS)
the first GCS on admission to the NCCU was used for this measure. Illness severity was scored
using the APACHE®IV score based on chart abstraction data in the first 24 h following
admission.
Procedures
Prior to enrolling the first subject, and throughout the study, nurses were provided with a review
of their education about sedation assessment using the Ramsay scale as well as with BIS
monitoring. Nurses were given an education sheet and individual instruction with detailed
information about interpreting BIS values that included a discussion on electromyographic
(EMG) and signal quality index (SQI) as indicators of the extent to which the BIS is providing
quality data. The legal representative of the patients was approached for the study within 24 h
of being intubated, or with 24 h of admission to the NCCU if they arrived intubated. After
obtaining consent, the subjects were randomized, via random number table, to either the
Ramsay-only or BIS-augmentation group. The study period began at 8:00 a.m. on the morning
following consent and lasted for 12 h (one nursing shift). Nurses were instructed to adjust the
dose of propofol infusion to achieve a Ramsay score of 4 in the Ramsay-alone group and a
Ramsay score of 4 plus a BIS value between 60 and 70 in the BIS-augmentation group. There
were no specified assessment times nor frequency for either group, nor was a sedation algorithm
provided; the nurses were free to self-determine their decision-making process. Propofol (10
mg/ml) concentrations were standard for all subjects and BIS monitoring was done with BIS
VISTAtm monitors using the Quatro Sensors.
Both groups were treated according to the NCCU unit standards; every 2 h, Ramsay sedation
assessments were performed and then the sedation was stopped so the nurse could obtain a
neurological evaluation. In order to evaluate the best neurological function each patient was
capable of displaying, the care nurse was instructed to reduce sedative infusion sufficiently to
allowa patient to wake up and undergo a full clinical assessment. Recovery time, defined as
the time to arouse sufficiently once the sedation was turned off such that an advance practice
nurse (not associated with this study) could obtain a reliable comprehensive neurologic exam,
was obtained and recorded at 4 p.m. on the day of study.
Analysis
The primary endpoint for this study was the total dose of sedative drug (propofol) used in 12
h; testing the hypothesis that BIS-augmented sedation reduces overall sedative use in
neurocritically ill patients. The a priori power analysis resulted in a planned enrollment of 90
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subjects (45 per group). To examine the primary endpoint, ANOVA was used to explore models
of sedative use over the course of a 12 h nursing shift. Next, two covariate models were tested
using the 4-step method of covariate analysis described by Cody and Smith [25]. The
association of BIS augmentation and time to wake-up (recovery time) when sedation was
stopped for neurologic examination was compared by using ANOVA. Finally we assessed
whether there were differences in the number of events associated with undersedation for
patients assigned to the BIS augmentation group compared with those assigned to Ramsay
alone.
Results
Subject enrollment included 67 patients; enrollment was terminated following a planned
interim analysis in which a significant clinical benefit was found in favor of the BIS-augmented
group (P = .0146). Of the 67 subjects enrolled in the study, 35 were randomized to the Ramsay-
alone group, while 32 received BIS-augmentation (Table 1). Subjects were representative of
patients admitted to the NCCU. Age, gender, ethnicity, and weight were evenly distributed
among the two groups. There were no differences between groups in terms of injury severity
(GCS scores; P = .192) or illness severity (APACHE®IV scores; P = .113). Groups were also
similar with respect to admission diagnosis (Table 1). Titrating sedative infusion using the
BIS-augmentation strategy was associated with a nearly 50% reduction in the mean total dose
of drug given over 12 h (93.5 ml, SD = 86.3) compared with the Ramsay-alone group (157.8
ml, SD = 119.2; P = .0146) (Table 2). A similar result was also seen when the mean weight-
based hourly infusion rate (mcg/kg/h) was assessed (BIS-augmentation group 14.6 mcg/kg/
min, SD = 12.2 versus Ramsay-alone group 27.9 mcg/kg/min, SD = 20.5; P = .0026). When
the individual rates were examined for each hour of the study, there were 8 subjects in the
Ramsay-alone group and no subjects in the BIS-augmentation group with documented infusion
rates over 4 mg/kg/h (manufacturer’s recommended maximum dose) [26].
Sedation Assessment
Ramsay scores for both groups are described in Table 3. There were no statistically significant
differences noted in Ramsay scores nor in the distribution of scores for the two groups. In the
Ramsay-alone group there were 163 observations (mean = 4); 7 observations were scored
Ramsay = 1, and 29 as Ramsay = 6. In the BIS-augmentation group there were 152 observations
(mean = 4); 6 observations were scored Ramsay = 1, and 36 as Ramsay = 6. For subjects
assigned to the BIS-augmentation group, BIS values were downloaded directly from the BIS-
Vista monitor to a USB drive and entered into a MySQL database. Values associated with high
EMG values (>50) or with low SQI values (<50) were excluded from the analysis. There were
11,634 min of BIS monitoring with 941 min of EMG > 50 and 191 min of SQI < 50. The mean
BIS value was 51.41 (median 47, standard deviation 14.35) across the remaining 10,502 min;
scores ranged from 2 to 91 (see Fig. 1) and with an approximately normal distribution (positive
skew = 0.87).
Oversedation and Undersedation
The difference in mean recovery time for the BIS-augmentation group (mean = 1.24 min, SD
= 2.08) compared with the mean recovery time for the Ramsay-alone group (mean = 7.49 min,
SD = 7.54) was significantly lower (P < .0001). There were no undersedation events during
the 12 h course of study within either of the study groups.
Discussion
Our study found that BIS-augmentation resulted in patients receiving half as much sedative as
those whose sedation was guided by observation only. Moreover, these patients also were
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significantly more likely to receive propofol at rates that exceed the manufacturer’s
recommendation [26] compared with nurses who are provided with BIS data. BIS-augmented
sedation assessment was also associated with a more rapid emergence from sedation.
Decreasing sedative use in the BIS-augmented group appeared safe and was not complicated
by any increase in undersedation events. In this study, propofol was the primary sedative for
patients in the study and the only sedative that nurses adjusted during the study period. Fentanyl
was prescribed as a prn bolus medication for 7 subjects in the Ramsay-alone group and 5
subjects in the BIS-augmentation group; there was no difference in the amount of fentanyl
(Ramsay alone group = 350 mcg, BIS-augmentation group = 200 mcg) administered during
the 12 h study period.
In the BIS augmentation group, the BIS value mean (51.4) and median (47) were below the
BIS goal of 60–70. BIS values in healthy non-sedated volunteers will fall below 40 during
sleep [27]. It is not possible in this sample to determine if patients had lower consciousness
states due to sleep or due to sedation. A patient who is given light sedation is not prohibited
from also falling asleep, but without a rigorous testing (e.g., polysomnography) it is not possible
to fully test this hypothesis. There is general consensus that ICU patients are oversedated
[28]. Less sedation, as seen in this study, may not equate with least sedation; patients may still
be oversedated. Eight subjects in the Ramsay-alone group received propofol at a rate exceeding
the manufacturer’s recommended maximum dose during at least one of the 12 h of study (Fig.
2). Data on complications from excessive propofol (e.g., cardio-vascular or hepatic changes)
were not collected in this study but could be part of future studies.
Subject data were collected under the principle of intent-to-treat. Nine subjects (5 Ramsay-
alone, 4 BIS-augmentation) received very little sedation (Fig. 2). Following subject recruitment
and initiation of the study period, the propofol was weaned and the subject was extubated.
Without knowing the decision-making process of each practitioner, it is not possible to
determine if the method of assessment impacted the decision to extubate. There remains a
significant difference between groups for both propofol volume (P = .019) and propofol rate
(P = .012) when these subjects are excluded from the analysis.
The correlation between BIS values and Ramsay scores is low (Pearson correlation = −.28)
when the mean BIS values for the hour preceding the Ramsay assessment are compared to the
timed Ramsay assessment. However, given that sedation assessment with Ramsay is an
intermittent assessment of the patient’s ability to respond to stimuli whereas neurofunction
monitors provide a near-continuous assessment of the degree of cortical entropy based on a
unilateral frontal EEG lead, this is not surprising. These two values represent two different
domains of sedation assessment and are obtained from two different assessment methods;
different methods of assessing different domains of a single construct are not expected to highly
correlate [24].
Perfect sedation requires that the patient is neither over-nor undersedated. Given that both
conditions exist in different patients, it is counter-intuitive to expect that BIS-augmented
sedation would always result in less drug use. A study of BIS use for decreasing anesthesia
awareness found that BIS use did not appear to reduce anesthesia awareness when compared
to end-tidal anesthetic gas measurements [29]. Although BIS has been associated with reduced
sedative use in earlier studies [20,21], a more recent study found that BIS use did not decrease
drug dosing [30].
Clinical Implications
This study provides support that the use of BIS monitoring, when combined with current
methods of observational assessment, is associated with a decrease in the amount of sedative
used to maintain an adequate level of sedation for neurocritically ill patients without an
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increased risk of undersedation. The results of the study are most clearly applicable to patients
with neurological injuries but may be relevant to other populations.
Increased sedation is associated with higher risk of infection, prolonged length of mechanical
ventilation, longer hospital stay, increased cost, and increased mortality [31–34]. Weinert
found that although most patients are chronically oversedated, as few as 3% of the documented
observational scores indicate oversedation [31]. Combining observational and physiologic
assessment may enhance sedation management because nurses are being provided with more
information than either tool provides independently. This more comprehensive and continuous
assessment of the patient’s state was associated with a decrease in the incidence of
oversedation.
The patient who is maintained in a state of conscious sedation receives minimal sedative
infusion and will quickly awaken when the sedation is removed [35]. Subjects in the BIS-
augmentation group had a shorter recovery time than did their counterparts in the Ramsay-
alone group. The positive implications of this result are clinically relevant. It is routine practice
and important to awaken patients from sedation for the purpose of obtaining a neurologic exam.
A decrease in the amount of time it takes to begin that exam will reduce the negative patient
outcomes associated with halting sedation [16]. The additional implication is that if the patient
requires less time to arouse from sedation, then it follows that the nurse will also experience a
shortened time for which he/she is required to monitor for emergence from sedation, thus saving
nursing time and effort, and freeing the nurse to engage in other tasks.
There is no standardized definition of undersedation; in an effort to be as objective as possible,
for this study, undersedation was defined as any self-device removal event, or ventilatory
asynchrony (document by the respiratory therapist) [7]. During the 12 h study period, there
were zero undersedation events in either group. A Ramsay score of 1 is defined as being awake
and anxious and agitated, or restless, or both [18]. As shown in Table 3, documentation of
Ramsay scores equal to 1 were not significantly different for the Ramsay-alone group (7
instances) compared to the BIS-augmentation group (6 instances). It must be noted that this
study was not powered to detect a difference in undersedation events, and undersedation events
are notably rare. This study explored 12 h of care for a discrete patient population. Should these
results be replicated in a larger study that extends over a longer period of time, they would
support continued use of BIS as an adjunct to current sedation assessment tools.
Limitations
While our study did meet its primary goals, there is insufficient clinical data to precisely define
the ideal goal and range for BIS scores and therefore the target range chosen for this study (60–
70) may have been too narrow. It is not known how nurses interpreted the relationship between
target and observed scores. For example, a subject may have had a BIS value of 59, and the
nurse responsible for adjusting sedative infusion rate may have considered that to be ‘‘close
enough’’ therefore electing not to adjust the infusion rate while a different nurse may have
increased the infusion rate for the same BIS score.
The Hawthorne effect is a phenomenon wherein the participants in a study alter their behavior
because they know they are being observed, which will in turn bias the results, often toward
increasing a type II error. To preserve clinical equipoise and diminish the threat of introducing
a Hawthorne effect, nurses were informed that the principal aim of the study was to correlate
BIS and Ramsay with GCS scores while at the same time being instructed to achieve the
specified sedation goals. While every subject in the study was cared for by an ICU nurse, not
all nurses provide identical care; nursing personal and professional attributes could influence
sedation [5]. There are a large number of medications that may directly or indirectly affect
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sedative use (e.g., narcotics). Data on concurrent medication use were not part of this study
and is therefore a limitation.
Data were collected during a single 12 h day shift in a neurocritical care unit to increase internal
validity, but this also limits external validity. As a preliminary study of augmenting sedation
assessment it is logical to first explore the intervention over a discrete time frame during which
only 1 nurse would care for 1 patient. We cannot state from this study, whether nurses managing
patients with the Ramsay-alone approach would continue to oversedate their patients, given
the opportunity to care for them for several days at a time. Longer-term studies that include
individual nursing characteristics are needed to assess this. The choice to include only
neurocritical care patients is supported by published work that supports BIS for brain-injured
patients; future studies will include other patient populations [36].
The choice of sedation assessment tool is also very important. The Ramsay scale was used
because it was standard-of-care for this hospital and the nurses were most familiar with
Ramsay, thus we could compare standard-ofcare to standard-of-care-plus-BIS. Although at the
time that this study was started the Ramsay scale was presumed to be a validated tool [37,
38], a recent study finds the Ramsay scale is not reliable [12] and thus it could be argued that
the results of this study might have been different with a more validated sedation assessment
tool such as the Richmond Agitation-Sedation Scale (RASS) [39]. While BIS provided
continuous information, it is not known how often the RN assessed sedation using BIS. Tools
such as Ramsay and RASS are impractical for continuous assessment and the standard-of-care
was applied. It is unknown whether more frequent assessments using Ramsay would have
yielded similar results.
Conclusion
Sedation assessment augmented with neurophysiological monitoring should be considered for
the routine use of monitoring and caring for neurocritically ill patients who require sedation.
Sedation assessment augmented by BIS monitoring was associated with a decrease in the
amount of propofol used to maintain a safe level of sedation. Compared to subjects who were
sedated and monitored using only an observational measure of sedation, subjects in the BIS-
augmentation group experienced significantly shorter recovery times when sedation was
interrupted for a neurological examination. There was no difference in the number of
undersedation events associated, and therefore BIS monitoring provides a safe adjunct to
current sedation assessment. Physiologic sedation assessment tools with EEG-derived
parameters should not be seen as a possible replacement for nursing judgment but rather they
should be incorporated, and studied, as an adjunct and a compliment to observational methods
of sedation assessment. This small study supports the concept of BIS-augmented sedation
assessment as a tool to safely reduce sedative use in mechanically ventilated neurologically ill
patients. Additional studies with more diverse populations and larger samples sizes will be
beneficial in determining the ultimate role of EEG-derived monitors in sedation assessment.
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Distribution of BIS values for subjects randomized to the BIS-augmentation group
Olson et al. Page 10














Propofol infusion rates for the Ramsay-alone and BIS-augmentation group. Mean propofol
infusion rates (mg/kg/h) are shown for each individual (with minimum and maximum hourly
rates represented by vertical bars). Groups are separated by a space for visual clarity
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Table 1
Admission emographics for subjects
Variables Measure Ramsay-alone
group N = 35
BIS-augmentation
group N = 32
t-test of
difference
Age Mean (SD) 54.8 (15.14) 57.8 (19.82) n.s.
Weight Mean (SD) 77.9 (18.17) 83.1 (18.76) n.s.
Gender % female 40.00% 50.00% n.s.
Caucasian Percent 57.14% 56.25% n.s.
African American Percent 31.43% 37.50% n.s.
Native American Percent 8.57% 3.13% n.s.
Pacific Asian Percent 2.86% - n.s.
Hispanic Percent - 3.13% n.s.
Admit GCS Mean (SD) 8.4 (2.64) 7.6 (2.73) n.s.
APACHE IV Mean (SD) 67.4 (20.28) 75.64 (21.84) n.s.
Admission diagnosis
Hemorrhagic stroke a 14 19
Ischemic stroke 5 1
Traumatic brain injury 7 3
Encephalopathy 3 5
Spinal cord injury 2 3
Brain tumor 3 1
Myasthenic crisis 1 0
n.s. = no significant difference
a
Includes subarachnoid, ubdural, and intraparenchymal emorrhage/hematoma
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